To better evaluate the optic nerve and exclude other sources of demyelination (common in multiple sclerosis cases), a head MRI was performed, which found a hypersignal of the left optic nerve in ...

The resolution of optic neuritis in a patient with chronic lymphocytic leukemia (CLL) following corticosteroid treatment underscores the importance of early recognition and targeted intervention for ...

Background/Aims The aim of this study was to identify specific MRI characteristics of anterior ischaemic optic neuropathy (AION) and optic neuritis (ON) that would aid in the differentiation between ...

Aim: To study the involvement of the chemokine receptor CXCR3 and its ligands (CXCL9/Mig, CXCL10/IP-10, CXCL11/ITAC) in optic neuritis (ON). Methods: 30 patients with ON and 10 non-inflammatory ...

Acute optic neuritis is the initial presentation in up to 25% of people with multiple sclerosis (pwMS). 1 2 The unstratified risk of developing clinically definite MS 15 years’ after a demyelinating ...

Conclusion: Optic neuritis associated with COVID-19 (COVID-19 ON) predominantly presents with bilateral onset and optic disk edema. Orbital magnetic resonance imaging (MRI) demonstrates that COVID-19 ...

Abnormal magnetic resonance imaging (MRI) findings in patients with glaucoma may reveal nonspecific markers of optic nerve damage, according to a study published in Eye. These markers, which include ...

A Scientific Online Poster presented during the 2023 ARRS Annual Meeting, held April 16–20 on the island of Oahu, explained how the novel technique of three-dimensional (3D) slice-to-volume (SVR ...

An award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu explained how the novel technique of three-dimensional (3D) slice-to-volume (SVR) MRI ...

DUBLIN-- (BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of ...

DUBLIN-- (BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of ...